TLR2 recognizes a bacterial lipopeptide through direct binding

Thierry Vasselon1, Patricia A Detmers, Dominique Charron

  • 1Institut National de la Santé et de la Recherche Médicale Unité 396, Paris, France. vasselon@histo.chu-stlouis.fr

Insights

Toll-like receptor 2 (TLR2) directly binds bacterial lipoproteins, initiating innate immune responses. This study reveals TLR2

Area of Science:

  • Immunology
  • Molecular Biology

Background:

  • Toll-like receptors (TLRs) are crucial for innate immunity, recognizing bacterial products like LPS and lipoproteins.
  • While TLR signaling is well-studied, the mechanisms of TLR activation remain unclear.

Purpose of the Study:

  • To investigate the molecular mechanisms of TLR2 activation.
  • To determine if TLR2 directly binds bacterial lipoproteins.

Main Methods:

  • Used fluorescently labeled synthetic bacterial lipopeptide (sBLP) and soluble recombinant CD14 (rsCD14).
  • Observed sBLP binding to cells expressing TLR2 transgenes and to soluble TLR2 ectodomain.
  • Utilized a chimeric TLR2/TLR4 construct to identify the ligand-binding domain.

Main Results:

  • Demonstrated direct interaction between the extracellular domain of TLR2 and sBLP.
  • Showed TLR2-mediated sBLP binding occurs independently of intracellular signaling.
  • Identified the leucine-rich region of TLR2 as responsible for agonist binding and signaling specificity.
  • Confirmed that soluble CD14 is required for sBLP binding to purified TLR2, but not part of the final complex.

Conclusions:

  • TLR2 directly recognizes synthetic bacterial lipopeptide (sBLP) through its extracellular domain.
  • The leucine-rich region of TLR2 dictates specificity for sBLP binding and subsequent signaling initiation.